Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-04-08

Clinical Trial Update: Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors

View source ↗

Summary

A clinical trial update discusses skin biopsies and DNA analysis in patients receiving irinotecan or gemcitabine for advanced solid tumors; the study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemcitabine (Gemzar) (gemcitabine)
  • Irinotecan (Camptosar) (Irinotecan)

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Breast Cancer, Colorectal Cancer | Status: COMPLETED